Damsma G, Tham C S, Robertson G S, Fibiger H C
Department of Psychiatry, University of British Columbia, Vancouver, Canada.
Eur J Pharmacol. 1990 Sep 21;186(2-3):335-8. doi: 10.1016/0014-2999(90)90456-g.
The effect of selective D1 receptor agonists on acetylcholine (ACh) release in the striatum was investigated using in vivo microdialysis. Administration of the reactive enantiomer, (+)-SKF 38393 (2, 10 mg/kg s.c.), doses which elevate grooming and sniffing behaviour, increased ACh release by 40 and 75%, respectively. Another D1 receptor agonist CY 204-283 (1 mg/kg s.c.) also produced a 75% increase in ACh output. The racemate (+/-)-SFK 38393 (20 mg/kg s.c.) increased ACh output by 60% and this was completely blocked by the D1 receptor antagonist SCH 23390 (0.3 mg/kg s.c.). In contrast, administration of the D2 receptor antagonist raclopride (1 mg/kg s.c.), 60 min after (+/-)-SKF 38393 (20 mg/kg s.c.), further increased ACh release. These results suggest that activation of D1 receptors increases ACh release in vivo and that D1 and D2 receptors have opposing roles in the regulation of striatal ACh release.
使用体内微透析技术研究了选择性D1受体激动剂对纹状体中乙酰胆碱(ACh)释放的影响。给予活性对映体(+)-SKF 38393(2、10mg/kg,皮下注射),这些剂量可提高梳理和嗅探行为,分别使ACh释放增加40%和75%。另一种D1受体激动剂CY 204-283(1mg/kg,皮下注射)也使ACh输出增加了75%。消旋体(±)-SFK 38393(20mg/kg,皮下注射)使ACh输出增加60%,这被D1受体拮抗剂SCH 23390(0.3mg/kg,皮下注射)完全阻断。相反,在(±)-SKF 38393(20mg/kg,皮下注射)60分钟后给予D2受体拮抗剂雷氯必利(1mg/kg,皮下注射),可进一步增加ACh释放。这些结果表明,D1受体的激活在体内增加ACh释放,并且D1和D2受体在纹状体ACh释放的调节中具有相反的作用。